Atlas Trials

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Clinical trial NCT07389044 · RECRUITING

Trial details

NCT number
NCT07389044
Sponsor
IntegerBio
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis B Virus Infection
Start date
2026-02-20
Primary completion
2027-04-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.